Skip to main content
Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.370
+0.170 (7.73%)
At close: Dec 20, 2024, 4:00 PM
2.380
+0.010 (0.42%)
After-hours: Dec 20, 2024, 6:43 PM EST

Nkarta Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
150
Market Cap
167.25M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019115.00K-6.44M-98.24%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fennec Pharmaceuticals 49.35M
2seventy bio 45.62M
Innate Pharma 36.20M
scPharmaceuticals 30.28M
Elutia 24.78M
Caribou Biosciences 11.48M
TScan Therapeutics 9.36M
Lyell Immunopharma 63.00K
Revenue Rankings

NKTX News

More News